GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2026)

GoodRx Holdings has disclosed Other Non-Current Liabilities across 8 years of filings, most recently posting $8.9 million for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities rose 25.78% year-over-year to $8.9 million; the TTM figure through Jun 2026 stood at $8.9 million (up 25.78% YoY), while the FY2025 annual figure was $8.7 million, up 29.4% from the prior year.
• Other Non-Current Liabilities came in at $8.9 million for Q2 2026 at GoodRx Holdings, up from $8.7 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $9.6 million in Q2 2023 to a low of $4.7 million in Q1 2022.
• Average Other Non-Current Liabilities over 5 years is $7.8 million, with a median of $7.9 million recorded in 2023.
• Year-over-year, Other Non-Current Liabilities declined 25.09% in 2022 and surged 70.04% in 2023.
• Over 5 years, Other Non-Current Liabilities stood at $7.6 million in 2022, then climbed by 8.2% to $8.2 million in 2023, then fell by 17.39% to $6.8 million in 2024, then rose by 29.4% to $8.7 million in 2025, then gained by 1.43% to $8.9 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $8.9 million in Q2 2026, $8.7 million in Q1 2026, and $8.7 million in Q4 2025.